Published in
Elsevier, Annals of Oncology, (27), p. vi241, 2016
DOI: 10.1093/annonc/mdw371.105
Links
Tools
Pembrolizumab vs best supportive care for second-line advanced hepatocellular carcinoma: Randomized, phase 3 KEYNOTE-240 study
Journal article published in 2016 by
R. Finn,
S. L. Chan 
,
A. X. Zhu,
J. Knox,
A.-L. Cheng,
A. Siegel,
O. Bautista,
P. A. Watson,
M. Kudo
,
A. X. Zhu,
J. Knox,
A.-L. Cheng,
A. Siegel,
O. Bautista,
P. A. Watson,
M. Kudo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 